With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
India's cheap weight-loss drugs could reshape global obesity fight
Date:
More like thisRelated
Motilal Oswal Sets New Stock Target Citing Attractive Valuations
Synopsis: The share of this company is in focus...
Clinical PSG Bury Chelsea To Reach Champions League Quarter-Finals
Paris Saint-Germain snuffed out any chance of a Chelsea...
‘We did a good job’: Trump hails US role in Iran war, says Tehran may take 10 years to rebuild
US President Donald Trump on Tuesday said...
नालंदा में लगी आग, 4 गैस सिलेंडर ब्लास्ट:डॉक्टर की कार भी जलकर राख, मॉर्निंग वॉक पर निकले लोगों ने देखी लपटें
नालंदा में बुधवार की सुबह आग लग गई। अगलगी...
